Amrize’s (AMRZ) Overweight Rating Reaffirmed at Stephens

Amrize (NYSE:AMRZGet Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Stephens in a report issued on Monday,Benzinga reports. They presently have a $65.00 target price on the stock. Stephens’ target price points to a potential upside of 30.64% from the stock’s current price.

Other analysts have also issued reports about the stock. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective for the company in a research note on Friday, May 1st. JPMorgan Chase & Co. increased their price target on shares of Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a report on Thursday, March 5th. Morgan Stanley reissued an “overweight” rating and set a $65.00 price target on shares of Amrize in a research report on Wednesday, May 6th. Oppenheimer set a $68.00 price objective on Amrize in a research report on Friday, May 1st. Finally, Royal Bank Of Canada lowered their target price on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $64.86.

Read Our Latest Stock Analysis on Amrize

Amrize Trading Up 1.5%

NYSE AMRZ opened at $49.76 on Monday. The stock has a market cap of $27.52 billion and a P/E ratio of 23.74. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The stock has a 50 day simple moving average of $55.74 and a two-hundred day simple moving average of $55.18. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. The business’s revenue was up 4.7% on a year-over-year basis. On average, analysts forecast that Amrize will post 2.7 earnings per share for the current year.

Insider Buying and Selling at Amrize

In other Amrize news, CEO Jan Philipp Jenisch acquired 60,000 shares of the stock in a transaction on Friday, March 6th. The stock was acquired at an average price of $58.05 per share, for a total transaction of $3,483,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,703,582 shares of the company’s stock, valued at $98,892,935.10. This trade represents a 3.65% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Ian A. Johnston purchased 4,250 shares of the stock in a transaction that occurred on Tuesday, March 10th. The stock was acquired at an average cost of $58.94 per share, with a total value of $250,495.00. Following the acquisition, the chief financial officer owned 25,110 shares in the company, valued at $1,479,983.40. The trade was a 20.37% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 77,836 shares of company stock valued at $4,511,449 over the last ninety days. Corporate insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Public Sector Pension Investment Board grew its holdings in shares of Amrize by 8.8% in the third quarter. Public Sector Pension Investment Board now owns 306,957 shares of the company’s stock worth $14,811,000 after purchasing an additional 24,738 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in Amrize by 4.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 4,601,319 shares of the company’s stock valued at $255,051,000 after buying an additional 214,393 shares during the period. Savvy Advisors Inc. purchased a new stake in Amrize in the 4th quarter valued at about $1,960,000. J. Safra Sarasin Holding AG grew its stake in Amrize by 31.3% in the 4th quarter. J. Safra Sarasin Holding AG now owns 112,250 shares of the company’s stock worth $6,174,000 after acquiring an additional 26,755 shares in the last quarter. Finally, 111 Capital bought a new position in Amrize in the 3rd quarter worth about $996,000.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.